COM:AFTPHARM
AFT Pharmaceuticals
- Stock
Last Close
2.71
25/11 04:00
Market Cap
309.35M
Beta: -
Volume Today
40.14K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 17.33M - | 21.57M 24.47% | 24.79M 14.93% | 23.95M 3.39% | 28.19M 17.74% | 33.58M 19.09% | 37.95M 13.02% | 45.73M 20.50% | ||
average payables | 7.34M - | 7.34M 0.01% | 7.00M 4.60% | 7.65M 9.19% | 11.66M 52.50% | 13.39M 14.77% | 17.13M 27.95% | 23.76M 38.71% | ||
average receivables | 15.66M - | 16.09M 2.76% | 15.53M 3.50% | 19.45M 25.27% | 25.93M 33.28% | 29.55M 13.96% | 34.74M 17.58% | 41.92M 20.66% | ||
book value per share | 0.92 - | 0.20 78.26% | 0.08 62.34% | 0.05 30.70% | 0.18 238.93% | 0.35 99.75% | 0.54 53.04% | 0.70 28.91% | 0.84 19.81% | |
capex per share | -0.02 - | -0.00 94.54% | -0.03 2,235.24% | -0.04 21.38% | -0.07 89.38% | -0.06 10.55% | -0.05 11.55% | -0.09 64.05% | -0.09 3.80% | |
capex to depreciation | -4.73 - | |||||||||
capex to operating cash flow | -0.37 - | |||||||||
capex to revenue | -0.01 - | -0.00 83.93% | -0.04 1,921.33% | -0.04 14.31% | -0.06 52.73% | -0.06 11.46% | -0.04 22.09% | -0.06 36.91% | -0.05 17.22% | |
cash per share | 0.92 - | 0.16 82.05% | 0.07 57.69% | 0.07 2.09% | 0.06 11.52% | 0.03 50.60% | 0.08 144.16% | 0.05 40.28% | 0.12 162.07% | |
days of inventory on hand | 159.65 - | 158.12 0.95% | 194.21 22.82% | 206.83 6.50% | 144.73 30.02% | 190.85 31.86% | 178.40 6.52% | 184.98 3.69% | 167.13 9.65% | |
days payables outstanding | 73.48 - | 62.07 15.52% | 58.35 5.99% | 54.86 5.99% | 54.89 0.06% | 83.38 51.90% | 64.27 22.92% | 96.79 50.61% | 86.29 10.85% | |
days sales outstanding | 88.07 - | 92.00 4.46% | 67.53 26.60% | 70.01 3.67% | 78.48 12.10% | 94.52 20.45% | 83.96 11.17% | 92.80 10.53% | 82.60 10.99% | |
debt to assets | 0.35 - | 0.40 13.43% | 0.54 34.62% | 0.66 21.22% | 0.54 17.41% | 0.40 25.94% | 0.33 17.15% | 0.26 22.76% | 0.18 31.72% | |
debt to equity | 0.82 - | 1.20 46.65% | 4.18 247.01% | 8.20 96.42% | 2.74 66.64% | 1.15 57.82% | 0.71 38.13% | 0.52 27.25% | 0.33 36.40% | |
dividend yield | 0.02 - | 0.00 - | 0.00 59.37% | 0.00 132.72% | 0.00 77.05% | 0.00 - | ||||
earnings yield | -0.15 - | -0.07 53.84% | -0.05 26.75% | -0.01 76.17% | 0.04 388.12% | 0.02 57.64% | 0.05 245.10% | 0.03 44.08% | 0.05 62.97% | |
enterprise value | 72.80M - | 264.79M 263.71% | 267.01M 0.84% | 229.45M 14.07% | 394.31M 71.85% | 550.33M 39.57% | 410.47M 25.41% | 396.08M 3.51% | 346.28M 12.57% | |
enterprise value over ebitda | -7.16 - | -18.75 161.88% | -27.60 47.24% | 35.43 228.35% | 18.16 48.73% | 44.27 143.72% | 19.44 56.10% | 19.42 0.08% | 13.46 30.67% | |
ev to operating cash flow | 13.55 - | |||||||||
ev to sales | 1.26 - | 3.83 203.78% | 3.34 12.84% | 2.70 19.12% | 3.75 38.59% | 4.88 30.14% | 3.16 35.16% | 2.54 19.60% | 1.77 30.28% | |
free cash flow per share | -0.02 - | -0.00 94.54% | -0.03 2,235.24% | -0.04 21.38% | -0.07 89.38% | -0.06 10.55% | -0.05 11.55% | -0.09 64.05% | 0.15 274.55% | |
free cash flow yield | -0.01 - | -0.00 94.23% | -0.01 2,375.36% | -0.02 51.72% | -0.02 4.34% | -0.01 34.40% | -0.01 21.28% | -0.03 71.17% | 0.05 294.19% | |
graham net net | 0.37 - | -0.00 101.02% | -0.20 5,085.61% | -0.28 39.50% | -0.36 31.86% | -0.26 29.13% | -0.17 33.47% | -0.18 6.57% | -0.07 61.76% | |
graham number | 3.00 - | 0.92 69.18% | 0.47 48.99% | 0.17 63.65% | 0.72 321.00% | 0.77 7.41% | 1.52 96.25% | 1.26 16.88% | 1.67 32.48% | |
income quality | 1.64 - | |||||||||
intangibles to total assets | 0.03 - | 0.04 35.36% | 0.09 106.64% | 0.13 43.28% | 0.31 139.26% | 0.31 0.40% | 0.31 0.52% | 0.31 1.50% | 0.32 4.97% | |
interest coverage | -5.74 - | -3.73 35.07% | -3.78 1.32% | 0.73 119.38% | 2.60 255.27% | 3.29 26.66% | 8.24 150.44% | 6.50 21.17% | 6.43 1.04% | |
interest debt per share | 0.82 - | 0.28 65.82% | 0.34 21.81% | 0.52 50.53% | 0.57 10.14% | 0.44 22.16% | 0.41 7.19% | 0.39 4.86% | 0.31 20.15% | |
inventory turnover | 2.29 - | 2.31 0.96% | 1.88 18.58% | 1.76 6.10% | 2.52 42.90% | 1.91 24.16% | 2.05 6.98% | 1.97 3.56% | 2.18 10.68% | |
invested capital | 0.82 - | 1.20 46.65% | 4.18 247.01% | 8.20 96.42% | 2.74 66.64% | 1.15 57.82% | 0.71 38.13% | 0.52 27.25% | 0.33 36.40% | |
market cap | 77.21M - | 257.35M 233.29% | 243.12M 5.53% | 194.62M 19.95% | 353.23M 81.50% | 511.32M 44.75% | 377.90M 26.09% | 362.78M 4.00% | 326.13M 10.10% | |
net current asset value | 22.51M - | 15.30M 32.02% | -949K 106.20% | -7.24M 663.22% | -14.46M 99.65% | -642K 95.56% | 12.53M 2,051.09% | 19.80M 58.11% | 28.27M 42.72% | |
net debt to ebitda | 0.43 - | -0.53 221.60% | -2.47 368.38% | 5.38 317.84% | 1.89 64.81% | 3.14 65.81% | 1.54 50.85% | 1.63 5.88% | 0.78 52.02% | |
net income per share | -0.43 - | -0.19 56.31% | -0.13 30.90% | -0.02 80.94% | 0.13 622.94% | 0.08 42.24% | 0.19 151.68% | 0.10 46.41% | 0.15 46.48% | |
operating cash flow per share | 0.24 - | |||||||||
payables turnover | 4.97 - | 5.88 18.37% | 6.25 6.37% | 6.65 6.37% | 6.65 0.06% | 4.38 34.17% | 5.68 29.74% | 3.77 33.60% | 4.23 12.18% | |
receivables turnover | 4.14 - | 3.97 4.27% | 5.41 36.23% | 5.21 3.54% | 4.65 10.79% | 3.86 16.98% | 4.35 12.58% | 3.93 9.53% | 4.42 12.35% | |
research and ddevelopement to revenue | 0.13 - | 0.16 28.63% | 0.10 36.64% | 0.03 70.40% | 0.02 38.18% | 0.03 61.54% | 0.04 39.28% | 0.04 14.54% | 0.04 14.27% | |
return on tangible assets | -0.21 - | -0.33 57.29% | -0.25 25.16% | -0.04 82.26% | 0.21 581.93% | 0.11 49.14% | 0.24 120.74% | 0.10 56.16% | 0.14 34.24% | |
revenue per share | 2.09 - | 0.71 66.00% | 0.82 15.53% | 0.87 6.18% | 1.08 24.00% | 1.09 1.02% | 1.24 13.52% | 1.49 19.82% | 1.86 25.39% | |
roe | -0.47 - | -0.94 100.96% | -1.73 83.50% | -0.48 72.49% | 0.74 254.29% | 0.21 71.08% | 0.35 64.45% | 0.15 58.43% | 0.18 22.27% | |
roic | -0.22 - | -0.34 50.37% | -0.26 21.66% | 0.14 153.35% | 0.30 113.34% | 0.14 55.13% | 0.21 56.84% | 0.11 48.24% | 0.14 31.09% | |
sales general and administrative to revenue | 0.11 - | 0.08 20.27% | 0.10 22.73% | 0.08 18.41% | 0.09 2.02% | 0.07 20.33% | 0.06 13.18% | 0.07 19.22% | 0.06 19.60% | |
shareholders equity per share | 0.92 - | 0.20 78.26% | 0.08 62.34% | 0.05 30.70% | 0.18 238.93% | 0.35 99.75% | 0.54 53.04% | 0.70 28.91% | 0.84 19.81% | |
stock based compensation to revenue | ||||||||||
tangible asset value | 23.53M - | 16.92M 28.09% | 2.22M 86.86% | -3.15M 241.55% | -9.73M 209.05% | 3.87M 139.76% | 18.65M 382.19% | 27.64M 48.20% | 34.34M 24.22% | |
tangible book value per share | 0.85 - | 0.17 79.58% | 0.02 86.88% | -0.03 241.46% | -0.10 209.05% | 0.04 137.45% | 0.18 375.81% | 0.26 47.96% | 0.33 24.20% | |
working capital | 43.37M - | 38.73M 10.71% | 29.70M 23.29% | -7.24M 124.38% | 30.23M 517.42% | 35.80M 18.41% | 48.49M 35.45% | 54.83M 13.06% | 59.66M 8.82% |
All numbers in (except ratios and percentages)